ProShares Ultra Industrials (UXI)
Live price chart, market sentiment, and community perspectives for ProShares Ultra Industrials (AMEX: UXI).
Live price chart, market sentiment, and community perspectives for ProShares Ultra Industrials (AMEX: UXI).
On our desk, looking at the recent Form 13F filings, we noticed IMC Chicago LLC increased its stake in UXI by 68.4% during the first quarter. However, overall institutional participation remains tightly bound, with only 11 funds holding roughly $4.7 million in total market value. This indicates that while specialized market makers are engaging with the vehicle, broad institutional sponsorship for this specific leveraged product remains narrow.
From a risk management standpoint, the dramatic contraction in short interest—down 88.5% in July to just 1,872 shares—suggests that bearish bets have virtually vanished from the tape. With only 0.4% of the shares shorted and a days-to-cover ratio sitting at 0.3 days based on an average daily volume of 7,057 shares, short squeezes are entirely off the table, leaving the asset entirely vulnerable to broad industrial sector momentum.
When evaluating the fund's mechanics for short-term allocation, it is crucial to remember its stated objective: UXI seeks daily investment results corresponding to two times the performance of the SandP Industrials Select Sector Index. As highlighted in the prospectus documents, holding these shares beyond a single day can result in performance divergence due to daily compounding effects, making it an active trading instrument rather than a buy-and-hold asset.
Analyzing the cost structure, UXI carries a gross expense ratio of 1.44% and a net expense ratio of 0.95% as of early 2026. For a leveraged ETF with a market capitalization of $32.7 million and relatively low daily liquidity, these fees alongside a 30-day SEC yield of 0.04% mean that holding costs will steadily eat into returns unless captured during sharp intraday moves in the underlying index.
When reviewing institutional flow metrics for Q1 2026, we observed zero new positions opened while one existing position was completely closed out, alongside two increases and four reductions. This lukewarm institutional turnover confirms that large capital allocators are treating UXI strictly as a tactical overlay rather than a core strategic holding within industrial sector allocations.
Explore plasma cleansing, somatic organ swaps, and BCI.